Divergene
The AI engine Fit Assessment
BetaDivergene leverages machine learning to enhance genomic data analysis and supports the expansion of therapeutics in gene therapy.
Blurb
HQ Location
Founded
Employees
Total funding raised
Last Funding Event
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
- Genomic Data Analysis
Developer of AI-driven analytics and informatics for the cell and gene therapy and bioprocessing industries. Divergene's services integrate multimodal data, break down data silos, and create advanced machine learning models to offer actionable insights. Their platform provides a secure and accessible environment for the standardization, computation, and analysis of multimodal data, helping organizations to retain ownership of their samples and data. Divergene collaborates with CROs, CDMOs, and cell and gene therapy companies to enhance their next-generation sequencing capabilities.